Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Maraviroc Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 25 mg Tablets
  • 1.4.3 75 mg Tablets
  • 1.4.4 150 mg Tablets
  • 1.4.5 300 mg Tablets
  • 1.4.6 20 mg/mL Oral Solution
• 1.5 Market by Application
  • 1.5.1 Global Maraviroc Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Maraviroc Market Size
• 2.2 Maraviroc Growth Trends by Regions
  • 2.2.1 Maraviroc Market Size by Regions (2014-2025)
  • 2.2.2 Maraviroc Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Maraviroc Market Size by Manufacturers
  • 3.1.1 Global Maraviroc Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Maraviroc Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Maraviroc Market Concentration Ratio (CR5 and HHI)
• 3.2 Maraviroc Key Players Head office and Area Served
• 3.3 Key Players Maraviroc Product/Solution/Service
• 3.4 Date of Enter into Maraviroc Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Maraviroc Market Size by Type (2014-2019)
• 4.2 Global Maraviroc Market Size by Application (2014-2019)

5 United States

• 5.1 United States Maraviroc Market Size (2014-2019)
• 5.2 Maraviroc Key Players in United States
• 5.3 United States Maraviroc Market Size by Type
• 5.4 United States Maraviroc Market Size by Application

6 Europe

• 6.1 Europe Maraviroc Market Size (2014-2019)
• 6.2 Maraviroc Key Players in Europe
• 6.3 Europe Maraviroc Market Size by Type
• 6.4 Europe Maraviroc Market Size by Application

7 China

• 7.1 China Maraviroc Market Size (2014-2019)
• 7.2 Maraviroc Key Players in China
• 7.3 China Maraviroc Market Size by Type
• 7.4 China Maraviroc Market Size by Application

8 Japan

• 8.1 Japan Maraviroc Market Size (2014-2019)
• 8.2 Maraviroc Key Players in Japan
• 8.3 Japan Maraviroc Market Size by Type
• 8.4 Japan Maraviroc Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Maraviroc Market Size (2014-2019)
• 9.2 Maraviroc Key Players in Southeast Asia
• 9.3 Southeast Asia Maraviroc Market Size by Type
• 9.4 Southeast Asia Maraviroc Market Size by Application

10 India

• 10.1 India Maraviroc Market Size (2014-2019)
• 10.2 Maraviroc Key Players in India
• 10.3 India Maraviroc Market Size by Type
• 10.4 India Maraviroc Market Size by Application

11 Central & South America

• 11.1 Central & South America Maraviroc Market Size (2014-2019)
• 11.2 Maraviroc Key Players in Central & South America
• 11.3 Central & South America Maraviroc Market Size by Type
• 11.4 Central & South America Maraviroc Market Size by Application

12 International Players Profiles

• 12.1 ViiV Healthcare
  • 12.1.1 ViiV Healthcare Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Maraviroc Introduction
  • 12.1.4 ViiV Healthcare Revenue in Maraviroc Business (2014-2019)
  • 12.1.5 ViiV Healthcare Recent Development
• 12.2 SANDOZ
  • 12.2.1 SANDOZ Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Maraviroc Introduction
  • 12.2.4 SANDOZ Revenue in Maraviroc Business (2014-2019)
  • 12.2.5 SANDOZ Recent Development
• 12.3 HETERO
  • 12.3.1 HETERO Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Maraviroc Introduction
  • 12.3.4 HETERO Revenue in Maraviroc Business (2014-2019)
  • 12.3.5 HETERO Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Maraviroc is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection.
In 2018, the global Maraviroc market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Maraviroc status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Maraviroc development in United States, Europe and China.

The key players covered in this study
ViiV Healthcare
SANDOZ
HETERO
...

Market segment by Type, the product can be split into
25 mg Tablets
75 mg Tablets
150 mg Tablets
300 mg Tablets
20 mg/mL Oral Solution

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Maraviroc status, future forecast, growth opportunity, key market and key players.
To present the Maraviroc development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Maraviroc are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.